PFE News 28.19 10/16/2014 05:37:13 Pfizer Inc (PFE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 28.19 $PFE

Most active New York Stock Exchange-traded stocks
AP - Wed Oct 15, 5:08PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
KMI: 35.29 (+0.79), GE: 24.28 (+0.18), F: 13.62 (-0.16), AA: 14.50 (+0.21), JPM: 55.53 (-2.46), AMD: 2.61 (-0.01), PFE: 28.19 (-0.27), C: 49.68 (-1.79), BAC: 15.76 (-0.76), WFC: 47.85 (-0.98), KEY: 12.14 (-0.75), TWTR: 49.99 (+1.41)

Final Glance: Pharmaceuticals companies
AP - Wed Oct 15, 5:08PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 98.21 (+1.20), BAX: 68.34 (-0.52), PFE: 28.19 (-0.27), BMY: 48.96 (+0.04)

3 Small-Cap Biotech Stocks to Buy if the Market Crashes
Todd Campbell, The Motley Fool - Motley Fool - Wed Oct 15, 1:38PM CDT
The Russell 2000  small-cap stock index is the most widely used proxy for small-cap stocks and the exchange traded fund that tracks that index  has tumbled 11.6% this year. That's a frightening drop, but it's been proven time and time again that...
JNJ: 98.21 (+1.20), INSY: 37.28 (+2.29), PTLA: 25.82 (+0.21), PFE: 28.19 (-0.27), MRK: 54.73 (-1.60), OPHT: 40.75 (+2.59), IWM: 106.60 (+1.06), BMY: 48.96 (+0.04), REGN: 334.75 (+6.68)

Midday Glance: Pharmaceuticals companies
AP - Wed Oct 15, 12:17PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 98.21 (+1.20), BAX: 68.34 (-0.52), PFE: 28.19 (-0.27), BMY: 48.96 (+0.04)

Shire Falls, AbbVie Questioned On Buyout Backtrack
at Investor's Business Daily - Wed Oct 15, 12:11PM CDT
Shares of specialty drugmaker Shire plummeted 23% on the stock market today after word got out late Tuesday that big pharma AbbVie is reconsidering its $55 billion buyout of the company. Shire (SHPG) confirmed the reports Wednesday morning with a...
ABT: 40.01 (-1.05), AZN: 68.41 (-1.40), PFE: 28.19 (-0.27), SHPG: 170.49 (-74.08), SLXP: 132.42 (-1.16), MYL: 47.38 (+0.56), ABBV: 54.63 (+0.50)

Pfizer (PFE) Breaks Through Support at $28.31
Comtex SmarTrend(R) - Wed Oct 15, 10:40AM CDT
Shares of Pfizer (NYSE FE) opened today below their pivot of $28.55 and have already reached the first level of support at $28.31. Should the shares continue to fall, the support pivots of $28.15 and $27.75 will be of interest.
PFE: 28.19 (-0.27)

Early Glance: Pharmaceuticals companies
AP - Wed Oct 15, 9:47AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 98.21 (+1.20), BAX: 68.34 (-0.52), PFE: 28.19 (-0.27), BMY: 48.96 (+0.04)

AbbVie Backs Away From Shire Takeover After Tax Changes
at The Street - Wed Oct 15, 9:27AM CDT
The Dublin target insists the deal should go ahead and notes that it's in line for a $1.635 billion breakup fee if it collapses.
MDT: 62.25 (-1.26), SHPG: 170.49 (-74.08), PFE: 28.19 (-0.27), COV: 85.86 (-6.50), ABBV: 54.63 (+0.50)

Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 15, 7:45AM CDT
If one drug is good, two drugs must be better. That seems to be what Johnson & Johnson and Bristol-Myers Squibb are thinking with the clinical trial collaboration agreement they entered to test Johnson & Johnson's Imbruvica with...
JNJ: 98.21 (+1.20), PCYC: 108.03 (+4.24), PFE: 28.19 (-0.27), MRK: 54.73 (-1.60), BMY: 48.96 (+0.04), NVS: 86.22 (-0.65)

FDA Sends Mixed Message On Safety of Pfizer inc.'s Chantix
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 15, 7:35AM CDT
Sales of Pfizer 's Chantix were knocked down a few years ago when the Food and Drug Administration slapped a black box warning on the smoking cessation drug after reports of patients experiencing neuropsychiatric events, including thoughts of...
PFE: 28.19 (-0.27), GSK: 43.13 (-0.55)

European Stocks Fall on Continued Worries Over Eurozone Economy
at The Street - Wed Oct 15, 4:58AM CDT
European stocks fall on Wednesday, failing to take their cue from a largely positive day in Asia as investors continue to worry about the outlook for the eurozone economy.
SHPG: 170.49 (-74.08), QCOM: 71.20 (-0.66), PFE: 28.19 (-0.27), MCHP: 37.73 (-0.48), AZN: 68.41 (-1.40), ABBV: 54.63 (+0.50)

Global Partial Seizure Clinical Trials Review, H2, 2014
M2 - Wed Oct 15, 3:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8gwn27/partial_seizure) has announced the addition of the "Partial Seizure Global Clinical Trials Review, H2, 2014" report to their offering. Partial Seizure Global Clinical Trials Review, H2, 2014 provides data on the Partial Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Partial Seizure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Partial Seizure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Partial Seizure Therapeutics Clinical Trials - UCB S.A. - Pfizer Inc. - Eisai Co., Ltd. - Novartis AG - Johnson & Johnson - GlaxoSmithKline plc - Bial - Portela & Ca, S.A. - SK Holdings Co., Ltd. - Upsher-Smith Laboratories, Inc. - Abbott Laboratories - National Institute of Neurological Disorders and Stroke - Emory University - Oregon Health & Science University - Kyoto University - National Center for Complementary and Alternative Medicine - Hadassah Medical Organization - University of Pennsylvania - Lawson Health Research Institute - Massachusetts General Hospital - University of California, Davis For more information visit http://www.researchandmarkets.com/research/8g...al_seizure
JNJ: 98.21 (+1.20), ABT: 40.01 (-1.05), PFE: 28.19 (-0.27), GSK: 43.13 (-0.55), NVS: 86.22 (-0.65)

Market Maker Surveillance Report. PFE, C, NOK, BAC, MSFT, GRPN, Bullishly Biased Price Friction For Tuesday, October 14th 2014
M2 - Wed Oct 15, 3:10AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4904 companies with "abnormal" market making, 2632 companies with positive Friction Factors and 2319 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. Pfizer Inc (NYSE FE), Citigroup Inc (NYSE:C), Nokia Oyj (NYSE:NOK), BANK OF AMERICA CORPORATION (NYSE:BAC), MICROSOFT CORPORATION (NASDAQ:MSFT), Groupon Inc (NASDAQ:GRPN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
C: 49.68 (-1.79), PFE: 28.19 (-0.27), BAC: 15.76 (-0.76), GRPN: 6.27 (+0.34), MSFT: 43.22 (-0.51), NOK: 7.77 (-0.19)

FDA: little evidence to drop Chantix boxed warning
By MATTHEW PERRONE - AP - Tue Oct 14, 5:57PM CDT
WASHINGTON (AP) — Federal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter warning from its anti-smoking drug Chantix about suicidal behavior.
PFE: 28.19 (-0.27)

Pfizer's Breast Cancer Candidate Gets Priority Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 5:00PM CDT
Pfizer Inc.'s (PFE) palbociclib is under the FDA's priority review for the first-line treatment in combination with Femara for ER+, HER2 advanced breast cancer.
AZN: 68.41 (-1.40), PFE: 28.19 (-0.27), LGND: 46.28 (+0.45), NVS: 86.22 (-0.65)

A Quick Look at Pfizer Inc.'s Drug Development Pipeline
Sean Williams, The Motley Fool - Motley Fool - Tue Oct 14, 1:15PM CDT
Source: StockMonkeys.com via Flickr The stock market offers plenty of industries for investors to choose from, but when it comes to looking deep into the future and basing a company's valuation more on promise than on its present-day products,...
PFE: 28.19 (-0.27), NVS: 86.22 (-0.65)

Can Dividend Stock GlaxoSmithKline plc Bounce Back?
George Budwell, The Motley Fool - Motley Fool - Tue Oct 14, 12:09PM CDT
The pharmaceutical industry has a bad rep when it comes to corruption in general and bribery in particular. For example, French drugmaker Sanofi  recently fessed up to U.S. authorities about an illegal payment scheme to doctors in East Africa and...
PFE: 28.19 (-0.27), MRK: 54.73 (-1.60), AMGN: 130.90 (-1.30), LLY: 62.87 (-0.27), GSK: 43.13 (-0.55), BMY: 48.96 (+0.04), SNY: 51.50 (-0.75), NVS: 86.22 (-0.65)

Where Will Celgene Corporation Stock Be a Year From Now?
Motley Fool Staff - Motley Fool - Tue Oct 14, 11:20AM CDT
Source: Celgene. The markets have gotten a little panicky lately, so last week we asked some of our top analysts to tell us what they think are the  best companies to buy in a time of tumbling ticker tape . One pick was Celgene , a biotech...
JNJ: 98.21 (+1.20), PFE: 28.19 (-0.27), AMGN: 130.90 (-1.30), CELG: 86.55 (+0.07)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Why Lear’s PACE Award Matters Beyond Seat Warmers Today

Updated Category News Views 111

Seat foam and wiring seldom make investors sit upright, yet Lear has managed to turn that unglamorous corner of the vehicle into something worth watching. The company’s Modular Thermal Comfort Systems just won a 2026 Automotive News PACE Award, a respected supplier-industry nod for innovation and business performance. Awards alone do not pay anybody’s bills, and I...

Continue Reading
Layne’s Jacksonville Debut Tests East Texas Expansion

Updated Category News Views 95

Jacksonville is not some flashy coastal launch, and that is precisely why this Layne’s Chicken Fingers opening matters. A new chicken tender shop at 1217 S. Jackson St. will not move public markets, because this is a franchise-growth story rather than a ticker story. But it does offer a clean look at whether Layne’s can turn its Texas roots into a durable multi-market...

Continue Reading
Roof Leaks Demand Diagnosis Before the Repair Bill

Updated Category News Views 95

A brown ring on a ceiling is often the last witness, not the crime scene. That is the useful, unglamorous point in Jonathan Floyd's HelloNation discussion of roof leaks: water has plenty of ways to move after it slips past a roof's defenses. Homeowners understandably stare at the stain and assume the answer sits directly overhead. Sometimes it does. Plenty of times, it...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 104

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Wallstreet Sand Hands Its Massive Permian Plant to Wilbanks

Updated Category News Views 210

A sand plant can brag about acreage and horsepower all day, but frac crews remember who kept material arriving when a completion schedule got ugly. That is the real backdrop to PI Holdings and Wallstreet Sand Co. naming Blaine Wilbanks president of both businesses on November 18, 2026. This is not a ceremonial chair swap. Wallstreet has built an enormous Permian sand...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 92

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Condo Downsizing Demands More Than a Price Check Today

Updated Category News Views 58

A smaller front door can hide a surprisingly large stack of obligations. That is the useful point in the HelloNation guidance featuring Chevy Chase real estate expert Lise Howe: downsizing into a condo is not merely a square-footage trade. It is a decision about recurring costs, building stewardship, daily friction, and whether the place still works when life gets less...

Continue Reading
BVM's Brookfield Headquarters Move Tests Growth Ambition

Updated Category News Views 152

A bigger office is rarely the exciting part of a growth story, yet it can reveal whether the machinery underneath is actually running hot. Best Version Media has moved its headquarters from Janacek Court to 15800 W. Bluemound Road, Suite 400, in Brookfield, Wisconsin, citing room for recent hires, future recruitment and closer collaboration across its print and digital...

Continue Reading
Vector Adds Mesa Division 10 Veteran for Arizona Growth

Updated Category News Views 135

A toilet-partition deal rarely raises eyebrows, but this one has the sturdy logic investors ought to notice. Vector Building Products has acquired Mesa-based Partitions & Accessories Co., a Division 10 specialist that has served Arizona contractors since 1978. It is not glamorous work. It is, however, the sort of necessary, specification-driven business that gets embedded...

Continue Reading
Zoomcar's November 23 Report Puts Execution on Trial

Updated Category News Views 55

A Date on the Board, Not a Verdict November 23 is when Zoomcar finally has to put some fresh numbers beside the story. The Bengaluru-based peer-to-peer car-sharing marketplace says it will release second-quarter fiscal 2027 financial and operating results that Monday, covering the quarter ended September 30, 2026. Management also plans a live webcast at 8:00 a.m. Eastern...

Continue Reading

Top 5 Most Recently Viewed Articles

Main Street Capital Reports Impressive Q2 2025 Financials

Updated Category News Views 326

Main Street's Second Quarter 2025 Financial Performance Main Street Capital Corporation (NYSE: MAIN) recently disclosed its remarkable financial results for the second quarter of 2025. The company reported a net investment income of $88.2 million, which translates to approximately $0.99 per share. Additionally, the distributable net investment income stood at $94.3...

Continue Reading
argenx's Q1 2025 Growth: VYVGART Performance Shines Brightly

Updated Category News Views 463

Q1 2025 Financial Results Unveiled by argenx argenx SE, listed on both Nasdaq and Euronext as ARGX, is making waves in the biotech industry with its recent announcement of first-quarter financial results and a comprehensive business update. CEO Tim Van Hauwermeiren expressed enthusiasm regarding the company's trajectory, focusing on their ambitious "Vision 2030"—a...

Continue Reading
Pennsylvania's Resilient Housing Market: An Overview of Trends

Updated Category News Views 135

Pennsylvania Housing Market Shows Notable Resilience The latest data on the housing market in Pennsylvania highlights an encouraging trend, as home prices have experienced a remarkable increase of 6.5% over the past year. This consistent appreciation indicates a vigorous market, even in the face of fluctuating economic conditions. Median Home Prices Reach New Heights In...

Continue Reading
Yum China's Strategy Bolstered by Pizza Hut Buy

Updated Category News Views 129

Yum China's Bold Step Forward Here's a twist in the fast-food market worth chewing on: Yum China has wrapped up its $1.2 billion acquisition of the Pizza Hut brand in Mainland China from Yum! Brands. It's like snagging the keys to a long-coveted car after being the chauffeur for decades. Strategic Flexibility and Margin Growth What's at play? Well, Joey Wat, CEO of Yum...

Continue Reading
Insightful Overview of NCC Group plc's Recent Trading Activity

Updated Category News Views 88

Understanding Recent Trading Activities of NCC Group plc In the fast-paced world of finance, keeping an eye on trading activities can offer invaluable insights. One company that has recently been under the spotlight is NCC Group plc. The trading revelations come from public disclosures made under Rule 8.5, indicating vital movements in their securities. Key Information...

Continue Reading